You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult angiosarcoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (drug,

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • pazopanib hydrochloride
  • +4 more
  • Chicago, Illinois
  • +4 more
Jul 26, 2022

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • Santa Monica, California
  • +6 more
Mar 29, 2022

Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in Denmark, Norway, Sweden (Propranolol,

Recruiting
  • Soft Tissue Sarcoma Adult
  • +2 more
  • Aarhus, Denmark
  • +3 more
Jul 23, 2023

Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

Completed
Has Results
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
Sep 23, 2021

Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

Not yet recruiting
  • Angiosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2023

Angiosarcoma of Skin Trial in Worldwide (Oraxol)

Active, not recruiting
  • Angiosarcoma of Skin
  • New York, New York
  • +9 more
Jan 31, 2023

Hepatic Small Vessel Neoplasm

Not yet recruiting
  • Hepatic Small Vessel Neoplasm
  • Imaging
  • (no location specified)
Oct 2, 2023

Locally Advanced Angiosarcoma, Metastatic Angiosarcoma, Recurrent Angiosarcoma Trial in Houston (Quality-of-Life Assessment,

Recruiting
  • Locally Advanced Angiosarcoma
  • +2 more
  • Quality-of-Life Assessment
  • Sintilimab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Malignant Melanoma, Angiosarcoma Trial in Chuo Ku (CICS-1 (investigational device),SPM-011(investigational drug))

Active, not recruiting
  • Malignant Melanoma
  • Angiosarcoma
  • CICS-1 (investigational device),SPM-011(investigational drug)
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
Nov 6, 2022

Angiosarcoma Metastatic Trial in Guangzhou (Abraxane combined with liposomal doxorubicin)

Recruiting
  • Angiosarcoma Metastatic
  • Abraxane combined with liposomal doxorubicin
  • Guangzhou, Guangdong, China
    Xing Zhang
Sep 4, 2022

Microvessel Ultrasound Imaging for Detecting Extent of Disease

Recruiting
  • Skin Angiosarcoma
  • Ultrasound Microvessel Imaging
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 14, 2023

Osteosarcoma, Bone Tumor, Bone Sarcoma Trial

Not yet recruiting
  • Osteosarcoma
  • +25 more
    • (no location specified)
    Aug 24, 2022

    Sarcoma Trial in United Kingdom (radiotherapy)

    Completed
    • Sarcoma
    • radiotherapy
    • Birmingham, England, United Kingdom
    • +5 more
    Mar 17, 2021

    Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)

    Recruiting
    • Advanced Cancer
    • +7 more
    • Scottsdale, Arizona
    • +14 more
    Sep 15, 2022

    Unresectable Angiosarcoma Trial in Tokyo (BNCT)

    Recruiting
    • Unresectable Angiosarcoma
    • BNCT
    • Tokyo, Japan
      National Cancer Center Hospital
    Nov 21, 2022

    Angiosarcoma of Skin Trial in Tampa (T-VEC)

    Active, not recruiting
    • Angiosarcoma of Skin
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Mar 22, 2022

    Angiosarcoma, Epithelioid Hemangioendothelioma Trial in Boston (Eribulin)

    Recruiting
    • Angiosarcoma
    • Epithelioid Hemangioendothelioma
    • Boston, Massachusetts
    • +1 more
    Feb 14, 2022

    Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone Trial in Shanghai (Camrelizumab and fluzoparib with concurrent stereotactic body

    Recruiting
    • Sarcoma
    • +2 more
    • Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University, School of Medici
    Oct 3, 2023

    Angiosarcoma Trial in Austria, Germany (Pazopanib + Paclitaxel)

    Terminated
    Has Results
    • Angiosarcoma
    • Pazopanib + Paclitaxel
    • Graz, Austria
    • +9 more
    Jan 21, 2022

    Angiosarcoma Trial in Amsterdam (Propranolol)

    Recruiting
    • Angiosarcoma
    • Amsterdam, Netherlands
      Netherlands Cancer Institute - Antoni van Leeuwenhoek
    Dec 20, 2021

    Angiosarcoma Trial (AGEN2034, AGEN1884)

    Withdrawn
    • Angiosarcoma
    • (no location specified)
    Dec 21, 2021

    Clinical Outcome of Treatment of Ulcerative Colitis in Adult

    Not yet recruiting
    • Ulcerative Colitis
      • (no location specified)
      Nov 20, 2023

      T2DM (Type 2 Diabetes) Trial in Beijing (HSK7653, Placebo)

      Completed
      • T2DM (Type 2 Diabetes Mellitus)
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Aug 1, 2023

      Severity in Juvenile and Adult-onset Dermatomyositis

      Not yet recruiting
      • Dermatomyositis
      • evaluation of clinical severity
      • (no location specified)
      Aug 16, 2023

      Chronic Hepatitis b Trial in Wuhan (TQA3038 injection, TQA3038 injection matching )

      Not yet recruiting
      • Chronic Hepatitis b
      • TQA3038 injection
      • TQA3038 injection matching placebo
      • Wuhan, Hubei, China
        Tongji Hospital
      Oct 17, 2023